MilliporeSigma
All Photos(1)

Documents

163015

Sigma-Aldrich

Thallium(III) nitrate trihydrate

All Photos(1)
Synonym(s):
TTN, Thallium trinitrate
Linear Formula:
Tl(NO3)3 · 3H2O
CAS Number:
13453-38-8
Molecular Weight:
444.44
EC Number:
237-325-4
MDL number:
MFCD00149874
PubChem Substance ID:
24850018
NACRES:
NA.22

Quality Level

100

reaction suitability

core: thallium
reagent type: catalyst

mp

102-105 °C (lit.)

SMILES string

O.O.O.[Tl+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O

InChI

1S/3NO3.3H2O.Tl/c3*2-1(3)4;;;;/h;;;3*1H2;/q3*-1;;;;+3

InChI key

ZCPIKMRXMBJLCP-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
325996150533425737
Thallium(III) nitrate trihydrate

Sigma-Aldrich

163015

Thallium(III) nitrate trihydrate

Thulium(III) nitrate pentahydrate powder or crystals, 99.9%

Sigma-Aldrich

325996

Thulium(III) nitrate pentahydrate

Thallium(III) trifluoroacetate technical grade

Sigma-Aldrich

150533

Thallium(III) trifluoroacetate

Thulium(III) trifluoromethanesulfonate 98%

Sigma-Aldrich

425737

Thulium(III) trifluoromethanesulfonate

mp

102-105 °C (lit.)

mp

-

mp

213 °C (dec.) (lit.)

mp

-

Application

Reagent for the rapid oxidation of styrene derivatives to carbonyl compounds, for the regioselective ring expansion of cyclic aralkyl ketones via oxidative rearrangement, for the selective hydrolysis of thioacetals to carbonyl compounds and for a general synthetic method to 19-norsteroids. Mediates ring contraction of cyclic ketones to a series of trans-fused 10-methyl-2-decalones.

Signal Word

Danger

Hazard Statements

H300 + H330 - H373 - H411

Hazard Classifications

Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - Aquatic Chronic 2 - STOT RE 2

Storage Class Code

5.1B - Oxidizing hazardous materials

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Product numbers are combined with Pack Sizes/Quantity when displayed on the website (example: T1503-25G). Please make sure you enter ONLY the product number in the Product Number field (Example: T1503).

Example:

T1503
Product Number
-
25G
Pack Size/Quantity

Additional examples:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

enter as 1.000309185)

Having trouble? Feel free to contact Technical Service for assistance.

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Aldrich Products

  • For a lot number such as TO09019TO, enter it as 09019TO (without the first two letters 'TO').

  • For a lot number with a filling-code such as 05427ES-021, enter it as 05427ES (without the filling-code '-021').

  • For a lot number with a filling-code such as STBB0728K9, enter it as STBB0728 without the filling-code 'K9'.

Not Finding What You Are Looking For?

In some cases, a COA may not be available online. If your search was unable to find the COA you can request one.

Request COA

Enrico Bugiardini et al.
Frontiers in neurology, 9, 456-456 (2018-07-13)
Objective: Distal myopathies are a diagnostically challenging group of diseases. We wanted to understand the value of MRI in the current clinical setting and explore the potential for optimizing its clinical application. Methods: We retrospectively audited the diagnostic workup in
Kevin Yauy et al.
The Journal of molecular diagnostics : JMD, 20(4), 465-473 (2018-04-25)
Interpretation of next-generation sequencing constitutes the main limitation of molecular diagnostics. In diagnosing myopathies and muscular dystrophies, another issue is efficiency in predicting the pathogenicity of variants identified in large genes, especially TTN; current in silico prediction tools show limitations
Synthetic Communications, 9, 301-301 (1979)
Journal of the American Chemical Society, 98, 3037-3037 (1976)
Sophie Lalande et al.
Experimental physiology, 102(9), 1055-1066 (2017-08-02)
What is the topic of this review? This review focuses on how in vivo and molecular measurements of cardiac passive stiffness can predict exercise tolerance and how exercise training can reduce cardiac passive stiffness. What advances does it highlight? This
View All Related Papers

Articles

Oxidizing and Reducing Agents

Oxidation and reduction reactions are some of the most common transformations encountered in organic synthesis

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service